One Company’s Clinical Miss Is Another’s Moat: Vertex Rallies as Sionna’s CF Bet Collapses
One daysingle sourceOne outlet reported this, once - no second voice in this corpus.
All 1 reports on Wed, 12 August 2026
What it is about
Who published it, and when
How it spread - 1 original report
Wed, 12 August 2026
1 report- yahoo.com03:41first to report
Cystic fibrosis investors came to learn a harsh lesson on August 10 about how concentrated a market can be: Sionna Therapeutics, Inc. (NASDAQ:SION) shares fell more than 90% following a key trial failure, while Vertex Pharmaceuticals (NASDAQ:VRTX), the company whose drug dominance Sionna was attempting to challenge, surged to new highs. The Pipeline Flop Sionna […]